Honolulu, HINCT07120334Now EnrollingIRB Ready

Stroke Recurrence Clinical Trial in Honolulu, HI

Access cutting-edge stroke recurrence treatment through this clinical trial at a research site in Honolulu. Study-provided care at no cost to qualified participants.

Sponsored by University of Hawaii

Quick Self-Assessment

See if you qualify for this Honolulu location

Preparing your pre-screening questions…

Expert Care in Honolulu

Access stroke recurrence specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related stroke recurrence treatment provided free

Apply for This Honolulu Location

Check if you qualify for this stroke recurrence clinical trial in Honolulu, HI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Honolulu

    Convenient for HI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Honolulu site if eligible
  4. 4Begin participation

About This Stroke Recurrence Study in Honolulu

Objectives: This study aims to test whether a mobile app called PortionSize Ed can help adults who have had a recent stroke and also have prediabetes or type 2 diabetes improve their diet. Specifically, we want to see if the app can help people follow a Mediterranean-style diet, which may lower the risk of future strokes and improve overall health. The main goals are to: * Test if the app is easy to use and acceptable to participants. * See whether the app helps people follow a healthier diet. * Look at changes in health indicators like blood sugar, cholesterol, blood pressure, and body fat. Design and Outcome: This is a randomized controlled pilot study that will involve 40 participants. All participants will be recruited from Queen's Medical Center after a recent stroke and will be randomly assigned to one of two groups: Intervention Group: Uses the full PortionSize Ed app, gets weekly reminders and educational videos, and has 3 sessions with a registered dietitian (RDN) over 12 weeks. Control Group: Uses a basic version of the app without feedback or RDN support, and receives usual care for stroke recovery. All participants will continue to receive standard care from Queen's, including the My Stroke Recovery Guide. The study lasts 12 weeks, with visits at the beginning and end to collect health data and feedback on the app. Schedule and Type of Evaluations/Interventions: Participants will complete the following: Baseline and Week 12 Visits: In-person assessments for blood sugar (HbA1c), cholesterol, blood pressure, height, weight, and body composition (using DXA, BIA, and 3D imaging), as well as surveys about their diet and activity levels. Intervention Group Only: * Three virtual counseling sessions with a registered dietitian (Week 1, 6, 12) * Weekly nutrition goal tracking and texting with the dietitian * Watching short educational videos through the app * Receiving app-based feedback on how well their diet follows Mediterranean Diet recommendations Duration of Study: The study will last 12 weeks for each participant, with an optional long-term follow-up using medical records. Sample Size and Population: The study will include 40 adults, ages 30 to 65, who: * Recently experienced a stroke * Have a history of prediabetes or type 2 diabetes * Are medically stable and able to use a smartphone (or willing to use a study-provided iPhone) * People will be excluded if they have severe swallowing issues, cognitive problems, or dietary needs that would make it hard to follow a Mediterranean-style diet.

Sponsor: University of Hawaii

Who Can Participate

Inclusion Criteria

Aged 30 to 65 years
Recent stroke (ischemic, hemorrhagic or Transient Ischemic Attack), within 1-14 days prior to enrollment
Confirmed diagnosis of prediabetes or type 2 diabetes, based on HbA1c results
Medically stable and cleared for oral diet and physical activity by the attending physician
Cleared for thin liquids and regular textures by physician
Capable of providing informed consent
Able to speak and read English
Owns a smartphone OR is willing to use a study-provided iPhone
Has sufficient cognitive and physical function to use a mobile app
Willing to participate in all study procedures and available for the 12-week duration

Exclusion Criteria

Severe dysphagia that prevents oral intake
Type 1 diabetes
Cognitive impairment (e.g., dementia, post-stroke confusion) that precludes consent or compliance, as judged by the clinical care team
Current participation in another interventional clinical trial
Pregnant or breastfeeding, or planning to become pregnant during the study period
Unwilling or unable to provide written informed consent
Serious comorbid conditions that, in the opinion of the

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Honolulu?

Yes, this clinical trial (NCT07120334) has an active research site in Honolulu, HI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Stroke Recurrence Treatment Options in Honolulu, HI

If you're searching for stroke recurrence treatment options in Honolulu, HI, this clinical trial (NCT07120334) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Honolulu research site is actively enrolling participants for this clinical trial. You'll receive care from experienced stroke recurrence specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all stroke recurrence clinical trials near you to find additional studies recruiting in your area.

More Stroke Trials in Honolulu, HI

See all stroke clinical trials recruiting in Honolulu — not just this study.

Browse Stroke Trials in Honolulu →

Browse More Trials by Condition

Ready to Join in Honolulu?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Honolulu, HI